The FDA has approved the first at-home, nonprescription test for chlamydia, gonorrhea, and trichomoniasis in women. The Visby ...

The FDA announced Friday that it had approved the first at-home test for sexually transmitted infections, opening the pathway for more to come.

The U.S. Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic ...

The US Food and Drug Administration has approved a single-use at-home test which can detect three STIs in women. Read on to ...

Visby Medical’s at-home diagnostic, which can be purchased without a prescription, tests for chlamydia, gonorrhea and ...

This is the first diagnostic test for chlamydia, gonorrhea and trichomoniasis that can be purchased without a prescription ...

The US Food and Drug Administration (FDA) has granted marketing authorization for the first at-home test to diagnose ...

Shiying Hao, Ph.D., from Stanford University in California, and colleagues used electronic health records to identify ...

US FDA grants marketing authorization of first home test for Chlamydia, gonorrhoea and trichomoniasis: Silver Spring, Maryland Monday, March 31, 2025, 10:00 Hrs [IST] The US Food ...

The US Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic test for chlamydia, gonorrhea, and trichomoniasis in women.

This at-home, nonprescription STI test has high positive accuracy rates in diagnosing chlamydia, gonorrhea, and trichomoniasis and has been FDA-approved for marketing. HealthDay News — The US ...

This approval follows authorization of the first at-home syphilis test last year and authorization of the first diagnostic test for chlamydia ... notes that women with positive results should ...